ArticleBMJ open2024

Multicentre double-blind randomised placebo-controlled trial evaluating the efficacy of the meningococcal B vaccine, 4CMenB (Bexsero), against

Kate L Seib et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.